Hawkins (HWKN) to Release Quarterly Earnings on Wednesday

Hawkins (NASDAQ:HWKN) is expected to be announcing its Q3 2026 results after the market closes on Wednesday, January 28th. Analysts expect the company to announce earnings of $0.75 per share and revenue of $252.51 million for the quarter. Parties can find conference call details on the company’s upcoming Q3 2026 earning report page for the latest details on the call scheduled for Wednesday, January 28, 2026 at 4:10 PM ET.

Hawkins (NASDAQ:HWKN) last announced its earnings results on Wednesday, October 29th. The specialty chemicals company reported $1.08 EPS for the quarter, missing the consensus estimate of $1.24 by ($0.16). Hawkins had a net margin of 7.95% and a return on equity of 17.42%. The firm had revenue of $280.43 million during the quarter, compared to analysts’ expectations of $284.42 million. On average, analysts expect Hawkins to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Hawkins Stock Down 0.1%

HWKN opened at $151.88 on Wednesday. Hawkins has a fifty-two week low of $98.30 and a fifty-two week high of $186.15. The firm has a market capitalization of $3.17 billion, a P/E ratio of 38.16, a PEG ratio of 2.35 and a beta of 0.86. The company’s 50-day moving average is $140.92 and its 200 day moving average is $156.59. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.43 and a quick ratio of 1.49.

Analyst Upgrades and Downgrades

Several equities analysts have commented on HWKN shares. Weiss Ratings cut shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 12th. Zacks Research raised Hawkins from a “strong sell” rating to a “hold” rating in a report on Friday, January 2nd. Finally, BWS Financial reiterated a “buy” rating and set a $200.00 price target on shares of Hawkins in a report on Monday, November 3rd. Two analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Hawkins currently has an average rating of “Hold” and an average target price of $162.50.

Insider Activity at Hawkins

In related news, VP Drew M. Grahek purchased 1,587 shares of the stock in a transaction that occurred on Monday, November 3rd. The shares were bought at an average price of $126.34 per share, with a total value of $200,501.58. Following the acquisition, the vice president owned 39,640 shares of the company’s stock, valued at $5,008,117.60. This trade represents a 4.17% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 4.10% of the company’s stock.

Institutional Trading of Hawkins

A number of large investors have recently bought and sold shares of HWKN. AQR Capital Management LLC raised its stake in shares of Hawkins by 9.0% in the first quarter. AQR Capital Management LLC now owns 12,331 shares of the specialty chemicals company’s stock valued at $1,306,000 after buying an additional 1,017 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Hawkins by 4.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,499 shares of the specialty chemicals company’s stock worth $1,218,000 after acquiring an additional 494 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Hawkins by 9.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 52,778 shares of the specialty chemicals company’s stock valued at $5,590,000 after acquiring an additional 4,400 shares during the period. Jane Street Group LLC raised its stake in Hawkins by 83.2% in the 1st quarter. Jane Street Group LLC now owns 38,416 shares of the specialty chemicals company’s stock valued at $4,069,000 after acquiring an additional 17,447 shares during the period. Finally, Invesco Ltd. lifted its holdings in Hawkins by 50.3% during the second quarter. Invesco Ltd. now owns 282,349 shares of the specialty chemicals company’s stock valued at $40,122,000 after purchasing an additional 94,503 shares during the last quarter. 69.71% of the stock is owned by hedge funds and other institutional investors.

About Hawkins

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.